12:15 PM – 2:00 PM

Addiction Medicine & Opioid-Agonist Treatment Curricula in High Demand by APRN Students

12:15 PM – 2:00 PM

Addressing the Opioid Crisis: Assessment of Clinicians in a Large Healthcare System

12:15 PM – 2:00 PM

An Opportunity to Intervene? The Opioid Epidemic and the Pennsylvania Warm Hand-off

12:15 PM – 2:00 PM

Are Long Hospital Stays Needed for Opioid Use Disorder and Injection-Related Infections?

12:15 PM – 2:00 PM

Assessing Risk of Cannabis Dependence Among Adolescent Dual Marijuana and e-Cigarette Users

12:15 PM – 2:00 PM

Association between Marijuana, Mental Health, and Tobacco in Colorado

12:15 PM – 2:00 PM

Barriers that Limit Emergency Department Staff from Distributing Take-Home Naloxone Kits

12:15 PM – 2:00 PM

Baseline Characteristics Predictive of Transition onto Extended-release Naltrexone

12:15 PM – 2:00 PM

BTOD REMS Program Surveillance Findings: Buprenorphine and Benzodiazepine Concomitant Use

12:15 PM – 2:00 PM

Caring for Patients With Opioid Use Disorder and Endocarditis: a Qualitative Study

12:15 PM – 2:00 PM

Ceasing to Require Stimulant Abstinence Increases Engagement in Buprenorphine Treatment

12:15 PM – 2:00 PM

Changes in Polysubstance Use Among Patients on Methadone for Opioid Use Disorder

12:15 PM – 2:00 PM

Changes in Substance Use Disorder Prevalence from 2008-2016: What about Stimulants?

12:15 PM – 2:00 PM

Characteristics of Patients Receiving Opioid Prescriptions from Primary Care Clinicians

12:15 PM – 2:00 PM

Characterizing the Presentation of Fentanyl-Related Overdoses Among People Who Use Drugs

12:15 PM – 2:00 PM

Contraceptive Knowledge of Patients Receiving Medication for Opioid Use Disorder

12:15 PM – 2:00 PM

Does Early Drinking Correlate to Risky Alcohol Use in College Students?

12:15 PM – 2:00 PM

Effects of Implementation of a Safe Opioid Prescribing Program in Hospital Medicine

12:15 PM – 2:00 PM

Evaluation & Standardization of a Substance Use Curriculum for Internal Medicine Residents

12:15 PM – 2:00 PM

Examining the Relationship Between Exposure to Marijuana Advertising & Recent Marijuana Use

12:15 PM – 2:00 PM

Expanded Buprenorphine Services through a Communiy Pharmacist Integrated Treatment Model

12:15 PM – 2:00 PM

Expanding Access to Buprenorphine Treatment in Rural Areas with Telemedicine

12:15 PM – 2:00 PM

Experience of School SBIRT in Middle and High School Students in Massachusetts

12:15 PM – 2:00 PM

Get Waivered: A Campaign to Get Emergency Physicians Waivered to Prescribe Buprenorphine

12:15 PM – 2:00 PM

HCV Screening Initiative for Patients Undergoing Inpatient Substance Abuse Treatment

12:15 PM – 2:00 PM

Heroin and Methamphetamine Withdrawal Symptoms, Frequency, and Pain Among People who Inject

12:15 PM – 2:00 PM

High Mortality Unaffected by Within-Prison Methadone Among Men with HIV Leaving Prison

12:15 PM – 2:00 PM

High Willingness to Use Rapid Fentanyl Test Strips Among Drug-Using Young Adults

12:15 PM – 2:00 PM

HIV and HCV Universal Screening in the Emergency Department: FOCUS Project

12:15 PM – 2:00 PM

Impact of RBP-6000 (Depot Buprenorphine) on Patient-Reported Outcomes: a Long-Term Study

12:15 PM – 2:00 PM

Implementation and Evaluation of an Interdisciplinary Prescription Opioid Safety Team

12:15 PM – 2:00 PM

Implementation of State Treatment Standards for Opioid Overdose and Opioid Use Disorder

12:15 PM – 2:00 PM

Improving HCV Care through Linkage to C Care Program in PWIDs

12:15 PM – 2:00 PM

Improving Nursing Provider Attitudes for Pregnant Women with Opioid Use Disorder

12:15 PM – 2:00 PM

Increasing Prevalence of Methamphetamine Use in Vancouver, Canada: a Sex-Based Analysis

12:15 PM – 2:00 PM

Integrated Therapies for Comorbid Substance Use and Anxiety/Depression: A Meta-Analysis

12:15 PM – 2:00 PM

Kratom Dependency: Case Review of Induction and Maintenance with Buprenorphine

12:15 PM – 2:00 PM

Low Barrier Buprenorphine Treatment for Homeless Patients with Opioid Use Disorders

12:15 PM – 2:00 PM

Medical Marijuana Users More Likely to Use Prescription Drugs Medically and Non-Medically

12:15 PM – 2:00 PM

Medical Student Bias Towards Patients with Addiction

12:15 PM – 2:00 PM

Medication Assisted Treatment for Opioid Use Disorders in Active Duty Military

12:15 PM – 2:00 PM

Mental Health and Addiction Diagnoses Predict Death in the Year Following Opioid Poisoning

12:15 PM – 2:00 PM

Methadone Maintenance Treatment for Fentanyl Use; Dose, Retention in Treatment and Relapse

12:15 PM – 2:00 PM

Online Sales of Marijuana: An Unrecognized Public Health Dilemma

12:15 PM – 2:00 PM

Opioid ECHO: Rapid Scaling of ECHO to Address the Opioid Epidemic

12:15 PM – 2:00 PM

Opioid, Other Drug Use Disorders and 30-Day Inpatient-Readmission in the US, 2010-2014

12:15 PM – 2:00 PM

Partnering to Expand MAT in RI's Department of Corrections: Improving Public Health

12:15 PM – 2:00 PM

Patient Reported Illicit Drug Use Screening by Healthcare Professionals, 2013-2015

12:15 PM – 2:00 PM

Perception of Executive Functioning Mediated by Impulsivity Predicts Heavy Alcohol Use

12:15 PM – 2:00 PM

Perspectives on Buprenorphine Adherence and Use of mHealth Technology to Address Barriers

12:15 PM – 2:00 PM

Prescription Opioid Misuse Among Adolescents Presenting to the Pediatric Emergency Dept

12:15 PM – 2:00 PM

Rapid Deployment of a Mobile Medical Unit During an Opioid Overdose Epidemic

12:15 PM – 2:00 PM

Recovery Houses in British Columbia, Canada & Drug-Related Risks and Harms

12:15 PM – 2:00 PM

Reduced Hospitalizations and Increased Abstinence Six Months After Recovery Coach Contact

12:15 PM – 2:00 PM

Social Media Use Among Patients Enrolled in Outpatient Addiction Treatment Programs

12:15 PM – 2:00 PM

Synthetic Cannabinoid Usage Among Psychiatric Inpatients

12:15 PM – 2:00 PM

Take-Home Naloxone for Patients with Opioid Use Disorder –Successful Opioid Reversals

12:15 PM – 2:00 PM

The Frequency and Geospatial Distribution of Publicly Discarded Needles in Boston, MA

12:15 PM – 2:00 PM

The Transition from Buprenorphine Maintenance to XR-NTX: a Randomized Double-Blind Study

12:15 PM – 2:00 PM

Transitioning Patients from Sublingual to Injectable Weekly and Monthly Buprenorphine